24 research outputs found
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1
Abdominal aortic aneurysm (AAA) is a common cause of morbidity and mortality and has a significant heritability. We carried out a genome-wide association discovery study of 1866 patients with AAA and 5435 controls and replication of promising signals (lead SNP with a p value < 1 Ă 10-5) in 2871 additional cases and 32,687 controls and performed further follow-up in 1491 AAA and 11,060 controls. In the discovery study, nine loci demonstrated association with AAA (p < 1 Ă 10-5). In the replication sample, the lead SNP at one of these loci, rs1466535, located within intron 1 of low-density-lipoprotein receptor-related protein 1 (LRP1) demonstrated significant association (p = 0.0042). We confirmed the association of rs1466535 and AAA in our follow-up study (p = 0.035). In a combined analysis (6228 AAA and 49182 controls), rs1466535 had a consistent effect size and direction in all sample sets (combined p = 4.52 Ă 10-10, odds ratio 1.15 [1.10-1.21]). No associations were seen for either rs1466535 or the 12q13.3 locus in independent association studies of coronary artery disease, blood pressure, diabetes, or hyperlipidaemia, suggesting that this locus is specific to AAA. Gene-expression studies demonstrated a trend toward increased LRP1 expression for the rs1466535 CC genotype in arterial tissues; there was a significant (p = 0.029) 1.19-fold (1.04-1.36) increase in LRP1 expression in CC homozygotes compared to TT homozygotes in aortic adventitia. Functional studies demonstrated that rs1466535 might alter a SREBP-1 binding site and influence enhancer activity at the locus. In conclusion, this study has identified a biologically plausible genetic variant associated specifically with AAA, and we suggest that this variant has a possible functional role in LRP1 expression
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers âŒ99% of the euchromatic genome and is accurate to an error rate of âŒ1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
Distribution and Cconnection to other Plant-Communities of Genista radiata (L.) Scop in the South Tyrol (Italy)
Es werden die Genista radiata-BestĂ€nde an der Mendel in SĂŒdtirol (Italien) beschrieben und ihr GesellschaftsanschluĂ diskutiert. Das Genisto-Festucetum alpestris Peer 83 besidelt steile sĂŒdexponierte KalkhĂ€nge der hochmontanen und subalpinen Stufe und ersetzt z.T. den ZwergstrauchgĂŒrtel mit Pinus mugo. Ăhnlich zusammengesetzt ist das Genisto-Festucetum alpestris pinetosum Peer 83, das in den ÂĄlockeren Erika-KiefernwĂ€ldern auftritt und bis in die tiefmontane Stufe hinunterreicht. Keinerlei syntaxonomische Bedeutung besitzt Genista radiata in den thermophilen Buschwaldgesellschaften, in denen die Pflanze lediglich eine Variante zum Orno-Ostryetum seslerietosum Peer 81 darstellt und speziell in der Saumzone anzutreffen ist. Auch in den LĂ€rchenwiesen der Kammlagen kommt Genista radiata nur sporadisch vor. Sie ist hier mit dem Festucetum nigrescentis laricetosum subass. prov. verzahnt.IstraĆŸene su vegetacijske sastojine vrste Genista radiata u juĆŸnom Tirolu i razmatrana njihova fitocenoloĆĄka pripadnost. Asocijacija Genisto-Festucetum alpestris Peer 83 nastava strme, juĆŸne vapnenaÄke obronke visokobrdskog i subalpskog pojasa. Subasocijacija Genisto-Festucetum alpestris pinetosum Peer 83 dolazi u rijetkim borovim ĆĄumama s crnjuĆĄom i spuĆĄta se do u niĆŸi brdski pojas. Termofilne niske ĆĄume, u kojima Genista radiata nema posebno sintaksonomsko znaÄenje, oznaÄene su samo kao varijanta zajednice Orno-Ostryetum seslerietosum Peer 81. Genista radiata dolazi takoÄer na travnjacima s ariĆĄem, ali samo sporadiÄno i to u mjeĆĄavini sa zajednicom Festucetum nigrescentis laricetosnm subass. prov.The Genista radiata-communities of the Mendel in the South Tyrol (Italy) are described and their connection to other plant-communities is discussed. Genisto-Festucetum alpestris Peer 83 settles on steep, south- exposed colcareous slopes of high-mountain and subalpine altitudes and replaces particularly the dwarf-shrub-belt with Firms mugo. Similar contents aire found in Genisto-F estucetum alpestris pinetasum Peer 83, which occurs in undensed Erico-Pinetum-communities and reaches down to the low-mountain-altitude. In the thermophilic bush-communities, in which Genista radiata is found only as a variant of Orneto-Ostryetum seslerie- tosum (Peer 81), the plant has no syntaxonomic importance. Genista radiata especially is found in the edge-zone. In the grassland of the larch- communities of the ridges Genista radiata appears only sporadically. Here the plant appeals in Festucetum nigrescentis laricetosum subass. prov
Animal-borne telemetry: An integral component of the ocean observing toolkit
Animal telemetry is a powerful tool for observing marine animals and the physical environments that they inhabit, from coastal and continental shelf ecosystems to polar seas and open oceans. Satellite-linked biologgers and networks of acoustic receivers allow animals to be reliably monitored over scales of tens of meters to thousands of kilometers, giving insight into their habitat use, home range size, the phenology of migratory patterns and the biotic and abiotic factors that drive their distributions. Furthermore, physical environmental variables can be collected using animals as autonomous sampling platforms, increasing spatial and temporal coverage of global oceanographic observation systems. The use of animal telemetry, therefore, has the capacity to provide measures from a suite of essential ocean variables (EOVs) for improved monitoring of Earth's oceans. Here we outline the design features of animal telemetry systems, describe current applications and their benefits and challenges, and discuss future directions. We describe new analytical techniques that improve our ability to not only quantify animal movements but to also provide a powerful framework for comparative studies across taxa. We discuss the application of animal telemetry and its capacity to collect biotic and abiotic data, how the data collected can be incorporated into ocean observing systems, and the role these data can play in improved ocean management
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990â2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56â604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100â000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100â000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100â000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100â000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100â000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
The Dominant Role of Extreme Precipitation Events in Antarctic Snowfall Variability
Antarctic snowfall consists of frequent clear-sky precipitation and heavier falls from intrusions of maritime airmasses associated with amplified planetary waves. We investigate the importance of different precipitation events using the output of the RACMO2 model. Extreme precipitation events consisting of the largest 10% of daily totals are shown to contribute more than 40% of the total annual precipitation across much of the continent, with some areas receiving in excess of 60% of the total from these events. The greatest contribution of extreme precipitation events to the annual total is in the coastal areas and especially on the ice shelves, with the Amery Ice Shelf receiving 50% of its annual precipitation in less than the 10Â days of heaviest precipitation. For the continent as a whole, 70% of the variance of the annual precipitation is explained by variability in precipitation from extreme precipitation events, with this figure rising to over 90% in some areas
The Dominant Role of Extreme Precipitation Events in Antarctic Snowfall Variability
Antarctic snowfall consists of frequent clear-sky precipitation and heavier falls from intrusions of maritime airmasses associated with amplified planetary waves. We investigate the importance of different precipitation events using the output of the RACMO2 model. Extreme precipitation events consisting of the largest 10% of daily totals are shown to contribute more than 40% of the total annual precipitation across much of the continent, with some areas receiving in excess of 60% of the total from these events. The greatest contribution of extreme precipitation events to the annual total is in the coastal areas and especially on the ice shelves, with the Amery Ice Shelf receiving 50% of its annual precipitation in less than the 10Â days of heaviest precipitation. For the continent as a whole, 70% of the variance of the annual precipitation is explained by variability in precipitation from extreme precipitation events, with this figure rising to over 90% in some areas
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
International audienceGastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is an autosomal-dominant cancer-predisposition syndrome with a significant risk of gastric, but not colorectal, adenocarcinoma. We mapped the gene to 5q22 and found loss of the wild-type allele on 5q in fundic gland polyps from affected individuals. Whole-exome and -genome sequencing failed to find causal mutations but, through Sanger sequencing, we identified point mutations in APC promoter 1B that co-segregated with disease in all six families. The mutations reduced binding of the YY1 transcription factor and impaired activity of the APC promoter 1B in luciferase assays. Analysis of blood and saliva from carriers showed allelic imbalance of APC, suggesting that these mutations lead to decreased allele-specific expression in vivo. Similar mutations in APC promoter 1B occur in rare families with familial adenomatous polyposis (FAP). Promoter 1A is methylated in GAPPS and sporadic FGPs and in normal stomach, which suggests that 1B transcripts are more important than 1A in gastric mucosa. This might explain why all known GAPPS-affected families carry promoter 1B point mutations but only rare FAP-affected families carry similar mutations, the colonic cells usually being protected by the expression of the 1A isoform. Gastric polyposis and cancer have been previously described in some FAP-affected individuals with large deletions around promoter 1B. Our finding that GAPPS is caused by point mutations in the same promoter suggests that families with mutations affecting the promoter 1B are at risk of gastric adenocarcinoma, regardless of whether or not colorectal polyps are present